Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/21/1991 | CA2032733A1 Topical pharmaceutical compositions |
12/21/1991 | CA2019577A1 Imidazo [2,1-b]thiazole compounds and anti-ulcer compositions containing the same |
12/20/1991 | CA2044786A1 Enantiomers of 2-tetrahydrofuran derivatives, intermediates, therefor, and their preparation |
12/19/1991 | WO1991019493A1 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
12/19/1991 | DE4114035A1 Adenosine-phosphate di:sodium and adenosine-tri:phosphate di:sodium - in aq. soln. for injection, are useful for treatment of psoriasis and neuro-dermatitis |
12/19/1991 | DE4019080A1 Use of new and known 3,7-di:aza-bi:cyclo(3,3,1)nonane derivs. - as diuretics for treating oedema, coronary insufficiency and hypertonia |
12/19/1991 | CA2044830A1 Inhibitors of hiv reverse transcriptase |
12/19/1991 | CA2044828A1 Inhibitors of hiv reverse transcriptase |
12/19/1991 | CA2044797A1 N-benzyl-n'-phenyl- and phenalkyl-thioureas |
12/19/1991 | CA2044694A1 Aminobenzodiazepines |
12/19/1991 | CA2043281A1 Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents |
12/18/1991 | EP0462075A2 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes |
12/18/1991 | EP0462067A1 Gemfibrozil formulations |
12/18/1991 | EP0462066A1 Amorphous gemfibrozil |
12/18/1991 | EP0462022A2 Anti-diabetic agents and veterinary anti-diabetic agents |
12/18/1991 | EP0462021A2 Cholesterol-lowering agents and veterinary cholesterol-lowering agents |
12/18/1991 | EP0462020A2 Anti-herpes agents and veterinary anti-herpes agent |
12/18/1991 | EP0462017A1 Process for the industrial preparation of 3-sulfamoyl-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide from 2,3-dihydro-2-methyl-1H-indole and hydroxylamine-O-sulfonic acid |
12/18/1991 | EP0462016A1 Process for the industrial preparation of 4-chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl) benzamide |
12/18/1991 | EP0462009A1 Cephalosporins having in position 3 a propenyl radical substituted by a quaternary ammonium, their process for preparation, their use as medicaments, compositions containing them and intermediates |
12/18/1991 | EP0462004A2 New use of modafinil |
12/18/1991 | EP0461986A1 Derivatives of hexahydroazepines, procedure for their preparation and pharmaceutical compositions containing same |
12/18/1991 | EP0461958A1 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivatives their production and their use in therapeutics |
12/18/1991 | EP0461827A2 Hair restorer |
12/18/1991 | EP0461815A1 Anti-HBV pyrimidine nucleoside |
12/18/1991 | EP0461707A2 Peptide oxytocin antagonists |
12/18/1991 | EP0461705A2 Agents for treating addiction to habit-forming drugs |
12/18/1991 | EP0461681A2 Use of quinazolines in the preparation of a medicament for treating and preventing arrhythmia |
12/18/1991 | EP0461593A1 Hair cleansing composition |
12/18/1991 | EP0461574A2 Medicines containing 3,7-diazabicyclo(3,3,1)nonanes |
12/18/1991 | EP0461559A2 Non active substance containing liposomes for the treatment of atherosclerosis |
12/18/1991 | EP0461556A1 Epipodophyllotoxin glycosides |
12/18/1991 | EP0461548A2 Method for preventing a second heart attack employing and HMG CoA reductase inhibitor |
12/18/1991 | EP0461530A2 Synergistic antimicrobial compositions |
12/18/1991 | EP0461520A2 Oxetanocin G anhydride crystals and process for producing the same |
12/18/1991 | EP0461505A1 Spray containing nitroglycerin |
12/18/1991 | EP0461499A2 Use of efomycins A, E and G as antiinflammatory agents |
12/18/1991 | EP0461427A2 Cyclodextrin complex |
12/18/1991 | EP0461407A1 Improved process for the preparation of 2-amino(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)adenine |
12/18/1991 | EP0461353A1 Biogenic amine uptake inhibitors |
12/18/1991 | EP0461343A1 Cyclopropachromen derivatives |
12/18/1991 | EP0461290A1 Capsules with a liquid content |
12/18/1991 | EP0461237A1 Use of 9,10-dihydrophenanthrene derivatives to prepare an antitumoral drug, and novel derivatives thereof. |
12/18/1991 | EP0461225A1 Circumvention of human tumor drug resistance |
12/18/1991 | EP0461223A1 Novel 1-triacontanol derivatives |
12/18/1991 | EP0461218A1 Oxypurinol salt composition for oral administration for treating hyperurecemia. |
12/18/1991 | EP0461145A1 Magnesium folates, process for their preparation and pharmaceutical compositions |
12/18/1991 | EP0288534B1 Compositions of catecholic butanes with zinc |
12/18/1991 | EP0174958B1 Treatment of high protein oedemas by direct application of benzo-pyrones |
12/18/1991 | CN1057049A Method for preparation of taxol |
12/18/1991 | CN1057003A Medicinal feed for systemic treatment of ectoparasitic and ectobacterial diseases of fish |
12/18/1991 | CN1057002A Preparation of compound rifampin (rfp) capsules |
12/18/1991 | CN1057001A Preparation of enteritislin capsules |
12/18/1991 | CN1015106B Process for preparing crystalline hydrate of oral cephalosporin |
12/18/1991 | CN1015105B Process for preparing oximino ether of 2,6-dioxabicyclo (3,3,0) octanones |
12/18/1991 | CN1015103B Process for preparing 3-halo-1-carbo-3-cephem-4-carboxylic acid and its deriv. |
12/18/1991 | CN1015102B Process for preparation of novel quinaldinamide derivs |
12/18/1991 | CA2019190A1 Method for preparing 2,3,3a,4,5,6-hexahydro-8-cyclohexyl-1h-pyrazino(3,2,1-j,k) carbazole hydrochloride and antidepressive drug based on this compound |
12/17/1991 | US5073671 1-(benzyl or pyridylmethyl)-4 or 5-aminomethyl-pyrrolidin-2-ones |
12/17/1991 | US5073641 Prodrug derivatives of carboxylic acid drugs |
12/17/1991 | US5073628 Hyposensitization agent |
12/17/1991 | US5073574 Tetrazolyl substituted benzonitriles and anti-tumor use thereof |
12/17/1991 | US5073571 Method of inhibiting virus |
12/17/1991 | US5073570 Mono-iodopropargyl esters of dicarboxylic anhydrides and their use as antimicrobial agents |
12/17/1991 | US5073569 Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
12/17/1991 | US5073568 Antipsoriatic agents |
12/17/1991 | US5073567 Milbemycins |
12/17/1991 | US5073566 Angiotensin ii antagonist 1,3-imidazoles and use thereas |
12/17/1991 | US5073563 Alkoxycoumarins substituted by a heterocyclic radical, their preparation and therapeutic agents containing these compounds |
12/17/1991 | US5073562 Antiinflammatory agents; leukotriene by antagonists |
12/17/1991 | US5073561 Methods of treating depression and psychoses |
12/17/1991 | US5073560 Spiro-isoxazolidine derivatives as cholinergic agents |
12/17/1991 | US5073559 2-Substituted purinone having phosphodiesterase inhibitory activity |
12/17/1991 | US5073557 Cognition activators, stimulants of central muscarinic acetylc holine receptors |
12/17/1991 | US5073555 Medicaments intended for combined use in the improvement of lymphocyte function to lower cholesterol levels |
12/17/1991 | US5073551 Cephalosporin compounds |
12/17/1991 | US5073548 Antiprogestational, progestational and antiglucocorticoid activity; glandular disorders; vision defects; antifertility agents |
12/17/1991 | US5073546 Antiinflammatory, analgesic, anticholesterol agent; psychological and nervous disorders |
12/17/1991 | US5073545 Agent containing an ellagic acid series compound for external application and use thereof |
12/17/1991 | US5073539 Transdermal administration of zwitterionic drugs |
12/17/1991 | US5073384 Containing simethicone; antiflatulents |
12/17/1991 | US5073380 Oral sustained release pharmaceutical formulation and process |
12/17/1991 | US5073376 Tablets or capsules containing tartaric acid for treatment of metabolic disorders |
12/17/1991 | US5073375 Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
12/17/1991 | US5073374 Drug delivery with active material, water soluble excipient an d lubricant |
12/17/1991 | US5073369 Efomycins as performance promoters in animals |
12/17/1991 | US5073366 Analgesic composition useful in providing a temporary relief from symptoms of arthritis |
12/17/1991 | US5073362 Dicarboxylic acid-bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) and x-ray contrast media containing them |
12/17/1991 | CA1293257C 6-(1h-tetrazol-5-yl)thieno[3,2-6]pyridin-5(4h)-one compounds |
12/17/1991 | CA1293256C2 Substituted benzoic acid alkylene bridged pyridil derivatives |
12/17/1991 | CA1293254C Substituted pyrrol-1-ylphenyldihydropyridazinones, their preparation and their use |
12/17/1991 | CA1293253C Antioestrogenic phenol derivatives |
12/17/1991 | CA1293249C 5-substituted 1,2,4-oxadiazole derivatives and preparation thereof |
12/17/1991 | CA1293248C2 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds |
12/17/1991 | CA1293247C Ergoline derivatives |
12/17/1991 | CA1293195C Antiatherosclerotic substituted ureas and thioureas |
12/17/1991 | CA1293194C Medicine based on fenofibrate, and a method of preparing it |
12/17/1991 | CA1293192C Compositions comprising 1-substituted azacycloalkanes |
12/16/1991 | WO1991019719A1 Substituted naphthoxazines useful as dopaminergics |
12/16/1991 | WO1991019503A1 Hyperosmotic solutions for isonatremic resuscitation |